nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.0262	0.036	CcSEcCtD
Pergolide—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.0235	0.0323	CcSEcCtD
Pergolide—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0208	0.0286	CcSEcCtD
Pergolide—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.0192	0.0263	CcSEcCtD
Pergolide—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0213	CcSEcCtD
Pergolide—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0207	CcSEcCtD
Pergolide—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0204	CcSEcCtD
Pergolide—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0172	CcSEcCtD
Pergolide—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0172	CcSEcCtD
Pergolide—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0164	CcSEcCtD
Pergolide—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0164	CcSEcCtD
Pergolide—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.015	CcSEcCtD
Pergolide—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00967	0.0133	CcSEcCtD
Pergolide—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00935	0.0128	CcSEcCtD
Pergolide—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00928	0.0127	CcSEcCtD
Pergolide—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.0092	0.0126	CcSEcCtD
Pergolide—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00834	0.0115	CcSEcCtD
Pergolide—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00829	0.0114	CcSEcCtD
Pergolide—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00801	0.011	CcSEcCtD
Pergolide—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00801	0.011	CcSEcCtD
Pergolide—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.0079	0.0109	CcSEcCtD
Pergolide—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.0079	0.0109	CcSEcCtD
Pergolide—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00785	0.0108	CcSEcCtD
Pergolide—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.0078	0.0107	CcSEcCtD
Pergolide—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00765	0.0105	CcSEcCtD
Pergolide—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00741	0.0102	CcSEcCtD
Pergolide—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00728	0.01	CcSEcCtD
Pergolide—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00715	0.00982	CcSEcCtD
Pergolide—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00703	0.00966	CcSEcCtD
Pergolide—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.00955	CcSEcCtD
Pergolide—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00684	0.00939	CcSEcCtD
Pergolide—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00665	0.00914	CcSEcCtD
Pergolide—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00665	0.00914	CcSEcCtD
Pergolide—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00658	0.00904	CcSEcCtD
Pergolide—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00635	0.00872	CcSEcCtD
Pergolide—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00632	0.00868	CcSEcCtD
Pergolide—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00632	0.00868	CcSEcCtD
Pergolide—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00851	CcSEcCtD
Pergolide—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.00834	CcSEcCtD
Pergolide—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.00819	CcSEcCtD
Pergolide—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00591	0.00811	CcSEcCtD
Pergolide—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00591	0.00811	CcSEcCtD
Pergolide—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00808	CcSEcCtD
Pergolide—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00585	0.00804	CcSEcCtD
Pergolide—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.0079	CcSEcCtD
Pergolide—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0057	0.00783	CcSEcCtD
Pergolide—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00563	0.00773	CcSEcCtD
Pergolide—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.00759	CcSEcCtD
Pergolide—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.00753	CcSEcCtD
Pergolide—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00747	CcSEcCtD
Pergolide—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00744	CcSEcCtD
Pergolide—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00524	0.0072	CcSEcCtD
Pergolide—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.00714	CcSEcCtD
Pergolide—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.00714	CcSEcCtD
Pergolide—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00688	CcSEcCtD
Pergolide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00665	CcSEcCtD
Pergolide—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.00642	CcSEcCtD
Pergolide—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00632	CcSEcCtD
Pergolide—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00627	CcSEcCtD
Pergolide—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.00615	CcSEcCtD
Pergolide—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00603	CcSEcCtD
Pergolide—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.00587	CcSEcCtD
Pergolide—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.0058	CcSEcCtD
Pergolide—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00416	0.00571	CcSEcCtD
Pergolide—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00413	0.00568	CcSEcCtD
Pergolide—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.00566	CcSEcCtD
Pergolide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00563	CcSEcCtD
Pergolide—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.00558	CcSEcCtD
Pergolide—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.00551	CcSEcCtD
Pergolide—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.004	0.0055	CcSEcCtD
Pergolide—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00548	CcSEcCtD
Pergolide—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00548	CcSEcCtD
Pergolide—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.00545	CcSEcCtD
Pergolide—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00544	CcSEcCtD
Pergolide—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00544	CcSEcCtD
Pergolide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00388	0.00533	CcSEcCtD
Pergolide—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.00528	CcSEcCtD
Pergolide—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.00525	CcSEcCtD
Pergolide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00503	CcSEcCtD
Pergolide—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00502	CcSEcCtD
Pergolide—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00498	CcSEcCtD
Pergolide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.00484	CcSEcCtD
Pergolide—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00468	CcSEcCtD
Pergolide—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00328	0.00451	CcSEcCtD
Pergolide—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.00449	CcSEcCtD
Pergolide—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00444	CcSEcCtD
Pergolide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00431	CcSEcCtD
Pergolide—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00429	CcSEcCtD
Pergolide—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00428	CcSEcCtD
Pergolide—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00425	CcSEcCtD
Pergolide—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00298	0.0041	CcSEcCtD
Pergolide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00406	CcSEcCtD
Pergolide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00294	0.00404	CcSEcCtD
Pergolide—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00402	CcSEcCtD
Pergolide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00394	CcSEcCtD
Pergolide—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00393	CcSEcCtD
Pergolide—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00391	CcSEcCtD
Pergolide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00381	CcSEcCtD
Pergolide—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00379	CcSEcCtD
Pergolide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00377	CcSEcCtD
Pergolide—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00372	CcSEcCtD
Pergolide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00372	CcSEcCtD
Pergolide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.00372	CcSEcCtD
Pergolide—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.00371	CcSEcCtD
Pergolide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00368	CcSEcCtD
Pergolide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00364	CcSEcCtD
Pergolide—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0036	CcSEcCtD
Pergolide—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00357	CcSEcCtD
Pergolide—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00354	CcSEcCtD
Pergolide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00349	CcSEcCtD
Pergolide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00345	CcSEcCtD
Pergolide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0034	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00325	CcSEcCtD
Pergolide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00323	CcSEcCtD
Pergolide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0032	CcSEcCtD
Pergolide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00318	CcSEcCtD
Pergolide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00317	CcSEcCtD
Pergolide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00314	CcSEcCtD
Pergolide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.0031	CcSEcCtD
Pergolide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00305	CcSEcCtD
Pergolide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00305	CcSEcCtD
Pergolide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00214	0.00294	CcSEcCtD
Pergolide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00292	CcSEcCtD
Pergolide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00282	CcSEcCtD
Pergolide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00282	CcSEcCtD
Pergolide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00256	CcSEcCtD
Pergolide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00252	CcSEcCtD
Pergolide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00244	CcSEcCtD
Pergolide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00236	CcSEcCtD
Pergolide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00227	CcSEcCtD
Pergolide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00225	CcSEcCtD
Pergolide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00225	CcSEcCtD
Pergolide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00223	CcSEcCtD
Pergolide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00212	CcSEcCtD
Pergolide—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000149	0.000546	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000148	0.000543	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000146	0.000538	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000146	0.000536	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000146	0.000536	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000145	0.000535	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000145	0.000533	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000143	0.000528	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000142	0.000522	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000141	0.000519	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000141	0.000518	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000141	0.000517	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000139	0.000513	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000139	0.000511	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000139	0.000511	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000139	0.000511	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000139	0.00051	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000138	0.000509	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000138	0.000508	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000138	0.000506	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000137	0.000504	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000137	0.000503	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000136	0.000501	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000136	0.000499	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000135	0.000497	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000133	0.00049	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000133	0.00049	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000133	0.000489	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000133	0.000487	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000132	0.000486	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000132	0.000486	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000131	0.000483	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000131	0.000483	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000129	0.000475	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000129	0.000474	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000129	0.000473	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000129	0.000473	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000128	0.000473	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000128	0.000471	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000128	0.00047	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000127	0.000469	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000127	0.000469	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000127	0.000469	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000127	0.000468	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000127	0.000467	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000127	0.000465	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000126	0.000464	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000126	0.000463	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000126	0.000463	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000125	0.000461	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000125	0.000461	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000125	0.00046	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000123	0.000453	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000121	0.000445	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00012	0.000443	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000118	0.000434	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000117	0.000431	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000117	0.00043	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000117	0.000429	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000117	0.000429	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000117	0.000429	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000116	0.000427	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000116	0.000425	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000115	0.000425	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000115	0.000424	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000115	0.000423	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000115	0.000423	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000115	0.000422	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000115	0.000421	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000114	0.00042	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000113	0.000417	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000113	0.000416	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000113	0.000415	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000112	0.000413	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000112	0.000412	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000112	0.000411	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000111	0.000409	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000111	0.000408	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00011	0.000406	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00011	0.000403	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000108	0.000397	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000107	0.000395	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000106	0.000391	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000106	0.000391	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000106	0.00039	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000106	0.00039	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000106	0.000389	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000105	0.000387	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000105	0.000385	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000105	0.000384	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000104	0.000384	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000104	0.000384	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000104	0.000382	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000104	0.000382	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000103	0.000379	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000102	0.000376	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000102	0.000376	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000102	0.000374	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000101	0.000372	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.0001	0.000368	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	9.9e-05	0.000364	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.88e-05	0.000363	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.88e-05	0.000363	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.83e-05	0.000361	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.76e-05	0.000359	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.75e-05	0.000359	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.71e-05	0.000357	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.67e-05	0.000356	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	9.67e-05	0.000356	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.62e-05	0.000354	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.59e-05	0.000353	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.59e-05	0.000353	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.59e-05	0.000353	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.58e-05	0.000352	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.51e-05	0.00035	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.39e-05	0.000345	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.38e-05	0.000345	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.23e-05	0.00034	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.2e-05	0.000338	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.08e-05	0.000334	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.08e-05	0.000334	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.92e-05	0.000328	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.92e-05	0.000328	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.85e-05	0.000326	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.81e-05	0.000324	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.77e-05	0.000323	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.73e-05	0.000321	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.67e-05	0.000319	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.65e-05	0.000318	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.61e-05	0.000317	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.59e-05	0.000316	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.57e-05	0.000315	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.53e-05	0.000314	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	8.38e-05	0.000308	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.35e-05	0.000307	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.33e-05	0.000306	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.31e-05	0.000306	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.31e-05	0.000306	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	8.27e-05	0.000304	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.2e-05	0.000302	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.2e-05	0.000302	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.2e-05	0.000302	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.2e-05	0.000301	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.14e-05	0.0003	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.08e-05	0.000297	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	8.04e-05	0.000296	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.98e-05	0.000294	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.96e-05	0.000293	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.91e-05	0.000291	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.87e-05	0.00029	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	7.85e-05	0.000289	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.68e-05	0.000282	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.66e-05	0.000282	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.58e-05	0.000279	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.58e-05	0.000279	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.56e-05	0.000278	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.53e-05	0.000277	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.44e-05	0.000274	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.4e-05	0.000272	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	7.38e-05	0.000272	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.37e-05	0.000271	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.37e-05	0.000271	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.33e-05	0.00027	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.28e-05	0.000268	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.22e-05	0.000265	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.21e-05	0.000265	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.15e-05	0.000263	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.11e-05	0.000262	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.1e-05	0.000261	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.07e-05	0.00026	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.95e-05	0.000256	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.92e-05	0.000254	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.84e-05	0.000252	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.84e-05	0.000251	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.81e-05	0.00025	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.8e-05	0.00025	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.78e-05	0.000249	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.77e-05	0.000249	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	6.72e-05	0.000247	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.69e-05	0.000246	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.6e-05	0.000243	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.57e-05	0.000242	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.57e-05	0.000242	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.39e-05	0.000235	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.39e-05	0.000235	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	6.35e-05	0.000233	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.3e-05	0.000232	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.3e-05	0.000232	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.29e-05	0.000231	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.27e-05	0.000231	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.22e-05	0.000229	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.17e-05	0.000227	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.07e-05	0.000223	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.05e-05	0.000222	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.8e-05	0.000213	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.7e-05	0.00021	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.69e-05	0.000209	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.64e-05	0.000208	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.62e-05	0.000207	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.59e-05	0.000205	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.53e-05	0.000203	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.49e-05	0.000202	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	5.48e-05	0.000202	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.47e-05	0.000201	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.44e-05	0.0002	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.32e-05	0.000196	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.23e-05	0.000192	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.19e-05	0.000191	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.19e-05	0.000191	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	5.15e-05	0.00019	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	5.12e-05	0.000188	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.89e-05	0.00018	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.83e-05	0.000178	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.83e-05	0.000178	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.83e-05	0.000178	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.82e-05	0.000177	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.75e-05	0.000175	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.65e-05	0.000171	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.65e-05	0.000171	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.55e-05	0.000167	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.48e-05	0.000165	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.45e-05	0.000164	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	4.38e-05	0.000161	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.36e-05	0.00016	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.32e-05	0.000159	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.28e-05	0.000157	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.21e-05	0.000155	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.19e-05	0.000154	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.07e-05	0.00015	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.03e-05	0.000148	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.01e-05	0.000147	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.98e-05	0.000146	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.98e-05	0.000146	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.7e-05	0.000136	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.64e-05	0.000134	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.59e-05	0.000132	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.56e-05	0.000131	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.47e-05	0.000128	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.45e-05	0.000127	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	3.36e-05	0.000124	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.36e-05	0.000123	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	3.35e-05	0.000123	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.31e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.3e-05	0.000122	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.05e-05	0.000112	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3e-05	0.00011	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.93e-05	0.000108	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.86e-05	0.000105	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.73e-05	0.0001	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	2.2e-05	8.08e-05	CbGpPWpGaD
